Phoenix Pharmahandel

Phoenix Pharmahandel is the German pharmaceutical distribution business associated with PHOENIX Group, a Mannheim-based healthcare company and one of Europe's largest pharmaceutical wholesalers. The company supplies prescription medicines, over-the-counter products, medical devices, and other pharmacy-related goods to pharmacies and medical institutions. Its operations combine wholesale distribution, pharmacy retail, and pharmaceutical services, giving the group a position across several stages of the medicines supply chain. The business was created in early 1994 through the combination of five German regional wholesalers: F. Reichelt AG in Hamburg, Otto Stumpf GmbH in Berlin, Ferd. Schulze GmbH in Mannheim, Otto Stumpf AG in Nuremberg, and Hageda AG in Cologne. The consolidation immediately gave the new company a leading position in its domestic markets. In 1995, the Phoenix brand was established and the group began an international expansion program covering Germany, Hungary, Italy, and the Netherlands. Key early transactions included a majority interest in Hungary's Parma Rt., a controlling interest in the northern Italian wholesaler Comifar, and a 60 percent stake in Dutch wholesaler ACF Holding. During the second half of the 1990s, Phoenix expanded into additional Central and Western European markets. It acquired or developed businesses in Italy, the Czech Republic, Hungary, Austria, Poland, France, and the United Kingdom. The British entry in 1998 included the creation of 11 distribution centres and acquisitions of L. Rowland & Co. and Philip Harris Medical. This expansion was intended to create a substantial competitor in the British pharmaceutical distribution market, alongside established operators such as AAH/Lloyds and Unichem/Moss. The group's scale increased substantially during the 2000s. Phoenix acquired an initial stake in Finland's Tamro Group in 2000 and completed the acquisition of all Tamro shares in 2004. Tamro was subsequently removed from the Helsinki Stock Exchange. Phoenix also merged Phoenix Pharmahandel AG & Co. KG with Ferd. Schulze GmbH & Co. in 2002. Group turnover passed several major thresholds during this period, while employee numbers rose above 10,000 in 2000 and 15,000 in 2002. Phoenix's business model has developed beyond conventional wholesaling. In addition to operating distribution centres, the group owns or manages pharmacy networks in multiple European countries, with many retail pharmacies operating under the BENU banner. It also provides pharmaceutical information and related services, including Phoenix Documentation, an online information resource covering medicines, ingredients, indications, and effects. These activities support pharmacies and healthcare professionals while strengthening the group's relationships with end customers. The group continued to broaden its European footprint through transactions and joint ventures. In 2016, Brocacef Groep, a joint venture between Phoenix and Celesio, acquired approximately 500 Mediq pharmacies in the Netherlands. In 2018, Phoenix acquired Romanian wholesaler Farmexim and the nationwide pharmacy chain Help Net Farma. The group has also held majority interests in businesses such as Purus in the Czech Republic and Tamro in Finland. PHOENIX Group's current activities span wholesale, pharmacy retail, and pharmaceutical services. Reference material describes a network of distribution centres serving markets across Europe, with operations extending to countries including Germany, the Nordic region, the United Kingdom, the Netherlands, Switzerland, Central Europe, the Balkans, Romania, and the Baltic states. Reported network totals vary by period and by whether particular subsidiaries, markets, or service operations are included. The group is predominantly owned by the Merckle Group and remains active as a privately held European healthcare enterprise.

Phoenix Pharmahandel was formed in early 1994 by bringing together five German regional pharmaceutical wholesalers: F. Reichelt AG, Otto Stumpf GmbH, Ferd. Schulze GmbH, Otto Stumpf AG, and Hageda AG. The consolidation created a company with a leading position in its German home markets from the outset. In 1995, the Phoenix brand was introduced and management began a broad international expansion program. The first international phase focused on Hungary, Italy, and the Netherlands. Phoenix acquired a majority holding in Parma Rt. in Hungary, a controlling stake in the northern Italian wholesaler Comifar S.p.A., and 60 percent of ACF Holding N.V., a major Dutch wholesaler based near Utrecht. Further acquisitions and branch openings followed in Italy, the Czech Republic, Hungary, Poland, and France. Difficulties in Poland and Hungary led to country-specific restructuring in 1997. During that year, Phoenix also acquired all of Austrian wholesaler Hestag and renamed Schulze Pharma France as Phoenix Pharma. Phoenix entered the United Kingdom in 1998 by establishing 11 distribution centres and acquiring L. Rowland & Co. and Philip Harris Medical. The move was intended to create a significant additional competitor in the British pharmaceutical distribution sector. The group continued to grow in the following years, passing 10,000 employees in 2000 and acquiring a 33.7 percent stake in the Finnish Tamro Group in April of that year. In 2002, Phoenix Pharmahandel AG & Co. KG merged with Ferd. Schulze GmbH & Co. The group then had more than 15,000 employees and reported turnover above EUR 15 billion according to the cited historical material. Phoenix completed the acquisition of Tamro in May 2004, taking ownership of all shares. Tamro was delisted from the Helsinki Stock Exchange in the same year. Phoenix's group-wide turnover subsequently passed EUR 20 billion in 2006; the source material also reports a later threshold of more than EUR 25 billion, although the relevant period is not consistently specified. The group pursued additional corporate and financial development during the 2010s. Standard & Poor's raised Phoenix's rating from B+ to BB- in July 2011 and retained a positive outlook. Moody's changed its outlook from stable to positive in August, while Fitch assigned a BB rating with a stable outlook in October. Phoenix issued a EUR 300 million corporate bond in May 2013. These financial figures are included as historical events rather than current financial indicators. Phoenix also expanded its pharmacy-retail activities. In 2016, Brocacef Groep, a joint venture between Phoenix and Celesio, acquired approximately 500 Mediq pharmacies in the Netherlands. In 2018, Phoenix acquired Farmexim, a Romanian pharmaceutical wholesaler, together with Help Net Farma, a Romanian pharmacy chain. The contemporary PHOENIX Group operates across wholesale, pharmacy retail, and pharmaceutical services. Its network has been described in different reference periods as comprising more than 160 distribution centres in Europe, while older descriptions cite more than 200 centres and different country totals. The group also operates thousands of pharmacies, many under the BENU brand, and serves pharmacies, medical institutions, and consumers. Its geographical presence includes Germany, the United Kingdom, the Netherlands, the Nordic region, Switzerland, Central and Eastern Europe, the Balkans, Romania, and the Baltic markets. The business remains predominantly owned by the Merckle Group.

• 2018

  Romanian expansion

  [1]Phoenix Pharmahandelen.wikipedia.org

  Phoenix acquires wholesaler Farmexim and pharmacy chain Help Net Farma in Romania.

• 2016

  Mediq pharmacy acquisition through Brocacef

  [1]Phoenix Pharmahandelen.wikipedia.org

  The Phoenix-Celesio Brocacef joint venture acquires approximately 500 Mediq pharmacies in the Netherlands.

• 2013

  Corporate bond issued

  [1]Phoenix Pharmahandelen.wikipedia.org

  Phoenix issues a corporate bond with a reported volume of EUR 300 million.

• 2004

  Tamro acquisition completed

  [1]Phoenix Pharmahandelen.wikipedia.org

  Phoenix takes full ownership of Tamro and Tamro is delisted from the Helsinki Stock Exchange.

• 2002

  Merger with Ferd. Schulze

  [1]Phoenix Pharmahandelen.wikipedia.org

  Phoenix Pharmahandel merges with Ferd. Schulze GmbH & Co., supporting further organizational consolidation.

• 2000

  Initial investment in Tamro

  [1]Phoenix Pharmahandelen.wikipedia.org

  Phoenix acquires a 33.7 percent stake in Finnish pharmaceutical wholesaler Tamro Group.

• 1998

  United Kingdom market entry

  [1]Phoenix Pharmahandelen.wikipedia.org

  Phoenix creates a British distribution network and acquires L. Rowland & Co. and Philip Harris Medical.

• 1995

  Phoenix brand and international rollout introduced

  [1]Phoenix Pharmahandelen.wikipedia.org

  The Phoenix name is established and expansion begins in Germany, Hungary, Italy, and the Netherlands.

• 1994

  Phoenix Pharmahandel is formed

  [1]Phoenix Pharmahandelen.wikipedia.org

  Five German regional pharmaceutical wholesalers combine to create Phoenix Pharmahandel, establishing a leading domestic distribution business.

A large, privately held European healthcare distribution group positioned as an infrastructure partner for pharmacies, medical institutions, pharmaceutical manufacturers, and consumers. Its differentiation comes from combining pharmaceutical wholesaling with pharmacy ownership and pharmaceutical services across multiple European markets.

• Healthcare distribution · 1994

  Pharmaceutical wholesale

  Phoenix distributes prescription medicines, over-the-counter products, medical devices, and other healthcare goods from pharmaceutical manufacturers to pharmacies, hospitals, and medical institutions. The service depends on a network of regional distribution facilities and frequent deliveries designed to help pharmacies maintain product availability.

• Pharmacy retail

  BENU pharmacies

  BENU is the principal pharmacy retail banner associated with PHOENIX Group in many European markets. The network provides prescription dispensing, over-the-counter medicines, health products, and pharmacist advice. The exact number of BENU locations varies by reporting period and market scope.

• Pharmaceutical information service

  Phoenix Documentation

  Phoenix Documentation is an internet-based medicine information archive. It provides structured information about medicines, their ingredients, indications, and effects, supporting pharmacy and healthcare-related information needs.

• Healthcare services

  Pharmaceutical services

  The group's services extend beyond physical distribution to pharmacy support, logistics, product information, and other services for pharmacies and pharmaceutical-sector participants. These activities help connect manufacturers, wholesalers, pharmacies, healthcare professionals, and patients.

• 2018

  Romanian wholesale and retail acquisitionM&A

  Background

  Phoenix sought to deepen its presence in Romania across both pharmaceutical distribution and pharmacy retail.

  Action taken

  The group acquired Farmexim and Help Net Farma.

  Aftermath

  Phoenix expanded its Romanian wholesale platform and pharmacy network.

  Source

• 2016

  Expansion of Dutch pharmacy retail through BrocacefM&A

  Background

  Phoenix and Celesio operated Brocacef Groep as a joint venture in the Netherlands.

  Action taken

  Brocacef acquired approximately 500 Mediq pharmacies.

  Aftermath

  The transaction strengthened the joint venture's position in Dutch pharmacy retail.

  Source

• 2004

  Full acquisition of TamroM&A

  Background

  Phoenix had held a minority stake in Finnish wholesaler Tamro since 2000.

  Action taken

  Phoenix acquired the remaining shares and took full ownership of Tamro.

  Aftermath

  The transaction became the largest acquisition in Phoenix's history according to the reference material, and Tamro was delisted from the Helsinki Stock Exchange.

  Source

• 1998

  Entry into the United KingdomStrategy

  Background

  The British pharmaceutical distribution market was dominated by established national operators.

  Action taken

  Phoenix established 11 distribution centres and acquired L. Rowland & Co. and Philip Harris Medical.

  Aftermath

  Phoenix developed a broad UK wholesale presence and also became associated with a pharmacy estate through the Rowlands business.

  Source

• 1995

  Launch of coordinated European expansionStrategy

  Background

  Following its formation from several German wholesalers, Phoenix sought to build a multinational pharmaceutical distribution platform.

  Action taken

  The company introduced the Phoenix brand and pursued majority investments and acquisitions in Hungary, Italy, and the Netherlands.

  Aftermath

  The move established the foundation for later expansion across Western, Central, Northern, and Eastern Europe.

  Source

1. 1Phoenix Pharmahandelen.wikipedia.org
2. 2PHOENIX Group official websitephoenixgroup.eu